WEBINAR
Using a Novel Automated Immunoassay to Streamline Batch Testing
During monoclonal antibody manufacturing, impurities like host cell proteins and protein A can affect product safety, quality, and stability. Downstream purification removes these impurities—but residual levels in your final product need careful monitoring.
This webinar shows how Gyrolab automates impurity quantification with nanoliter-scale immunoassays, helping you streamline batch release testing with greater consistency and less hands-on time than conventional ELISA.
What You Will Learn
- How Gyrolab automated immunoassay technology compares to traditional ELISA in performance and workflow
- How one biopharma improved method performance using Gyrolab's automated platform
- Real case studies: quantifying IgG titer, measuring residual impurities, and evaluating product potency with target binding assays
Speakers:
Fabrice Cantais, Senior Scientist, Analytical Leader for Biologics, Servier
Kira Hedström, Application Scientist, Gyros Protein Technologies
If you have problems viewing the webinar, please contact maritha.lundin@gyrosproteintech.com